The importance of preoperative breast MRI for patients newly diagnosed with breast cancer

Breast Journal

Volumn 15, Issue 1, 2009, Pages 52-60

  Crowe, Joseph P ^a,b   Patrick, Rebecca J ^a   Rim, Alice ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

Breast cancer; Breast cancer risk assessment; Breast magnetic resonance imaging; Mastectomy; Partial mastectomy; Tumor stage

Indexed keywords

ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; MEDICAL PRACTICE; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROFESSIONAL PRACTICE; PROSPECTIVE STUDY; TUMOR BIOPSY;

BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 58149287964     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2008.00671.x     Document Type: Article

References (39)

1. Damadian R. Tumor detection by nuclear magnetic resonance. Science 1971 171 : 1151 3.
2. Kuhn TS. The Structure of Scientific Revolutions, 3rd edn. Chicago and London : U of Chicago P, 1996 : 176 84.
3. Yousef SJ, Duchesneau RH. Magnetic resonance imaging of the human breast: a phase I trial. Radiol Clin North Am 1984 22 : 859 68.
4. Ross RJ, Thompson JS, Kim K, Bailey RA. Nuclear magnetic resonance imaging and evaluation of human breast tissue: preliminary clinical trials. Radiology 1982 143 : 195 205.
5. Heywang SH, Hahn D, Schmidt H, et al. MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 1986 10 : 199 204.
6. Heywang SH, Basserman G, Fenzl W, et al. MRI of the breast - histopathologic correlation. Eur J Radiol 1987 7 : 175 82.
7. Schwartz GF, Patchesfsky AS, Feig SA, Shaber GS, Schwartz AB. Multicentricity of non-palpable breast cancer. Cancer 1980 45 : 2913 6.
8. Schwartz GF, Patchefsky AS, Feig SA, Shaber GS, Schwartz AB. Clinically occult breast cancer. Ann Surg 1980 191 : 8 12.
9. Holland R, Veling SHJ, Mravunac M, Hendriks HCL. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985 56 : 979 89.
10. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004 292 : 1317 25.
11. Harms SE, Morris E. ACR Practice Guideline for the Performance of Magnetic Resonance Imaging (MRI) of the Breast. (effective date 10/1/2004).
12. Wright H, Listinsky J, Rim A, et al. Magnetic resonance imaging as a diagnostic tool for breast cancer in premenopausal women. Am J Surg 2005 190 : 572 5.
13. Tillman GF, Orel SG, Schnall MD, Schultz DJ, Tan JE, Solin LJ. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. JCO 2002 20 : 3413 23.
14. Schelfout K, van Goethem M, Kersschot E, et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. EJSO 2004 30 : 501 7.
15. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001 220 : 13 30.
16. Drew PJ, Sumohan C, Turnbull LW, et al. Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to the triple assessment for the pre-operative detection of multifocal breast cancer. Ann Surg Oncol 1999 6 : 599 603.
17. Deurloo EE, Zeggelink WFAK, Teertstra HJ, et al. Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients. Eur Radiol 2006 16 : 692 701.
18. Gundry KR. The application of breast MRI in staging and screening for breast cancer. Oncology 2005 19 : 159 77.
19. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993 187 : 493 501.
20. Harms SE, Flamig DP. Staging of breast cancer with MR imaging. Magn Reson Imaging Clin N Am 1994 2 : 573 84.
21. Galinsky D, Kisselgoff D, Sella T, Peretz T, Libson E, Sklari-Levy M. Effect of breast magnetic resonance imaging on the clinical management of breast cancer. IMAJ 2005 7 : 700 3.
22. Fisher U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999 213 : 881 8.
23. Esserman L, Hylton N, Yassa L, Barclay J, Frankel S, Sickles E. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. JCO 1999 17 : 110 9.
24. Boetes C, Mus RDM, Holland R, et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 1995 197 : 743 7.
25. Kneeshaw PJ, Turnbull LW, Smith A, Drew PJ. Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer. EJSO 2003 29 : 32 7.
26. Kepple J, Layeeque R, Klimberg S, et al. Correlation of magnetic resonance imaging and patholofic size of infiltrating lobular carcinoma of the breast. Am J Surg 2005 190 : 623 7.
27. Slanetz PJ, Edmister WB, Yeh ED, Talele AC, Kopans DB. Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J 2002 8 : 145 8.
28. Rieber A, Merkle E, Bohm E, Brambs HJ, Tomczak R. MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Somogr 1997 21 : 773 9.
29. Lehman CD, Blume JD, Thickman D, et al. Added cancer yield of MRI screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) Trial. J Surg Oncol 2005 92 : 9 16.
30. Lee SG, Orel SG, Woo IJ, et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 2003 226 : 773 8.
31. Lagios MD, Westdahl PR, Rose Marye R. The concept and implications of multicentricity in breast carcinoma. Pathology Annu 1981 16 : 83 102.
32. Orel SG, Schnall MD, Powell CM, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995 196 : 115 22.
33. Morrow M. Magnetic resonance imaging in breast cancer. One step forward, two steps back?. JAMA 2004 292 : 2779 80.
34. Hylton N. Magnetic resonance imaging of the breast: opportunities to improve breast cancer management. J Clin Oncol 2005 23 : 1678 84.
35. Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 2003 98 : 468 73.
36. Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998 16 : 2672 85.
37. Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 2001 30 : 96 102.
38. Fischer U, Zachariae O, Baum F, von Heyden D, Funke M, Liersch T. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 2004 14 : 1725 31.
39. Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer 1986 57 : 1717 24.